Skip to content

Anderson Study 1 - Tart Cherry Study

Effects Of Tary Cherry Ingestion On Food-Induced Serum Uric Acid Elevation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04837274
Acronym
AS1
Enrollment
24
Registered
2021-04-08
Start date
2020-04-10
Completion date
2021-06-01
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Services Research

Brief summary

The purpose of this study is to examine if tart cherry reduces food-induced elevations in serum uric acid.

Detailed description

Gout is a painful form of arthritis that is caused by hyperuricemia (high uric acid levels) that form crystals in the joints. Ingestion of food and/or beverages containing high purine levels (e.g., beef, game meats, liver, shellfish, herring, mackerel, anchovies, sardines, mushrooms, dried beans and peas, sweetbreads, excessive alcohol, etc.) increase uric acid levels and thereby can complicate the management of uric acid levels in individuals with hyeruricemia and/or gout. Prior research has shown that ingestion of a chrysanthemum flower oil containing a high level of polyphenols significantly reduced the uricemic response to ingesting a meal high in purines. Additionally, black cherry and grape juice extracts are purported to have uric acid lowering properties. We have previoulsy reported that tart cherry powder, another naturally occuriring source of phlyphenols, lessens exercise-induced inflammation. This study will examine if tart cherry can also reduce the uricemic response to ingesting a high purine containing meal. If so, this may provide another dietary approach to help individuals manage their uric acid levels.

Interventions

DIETARY_SUPPLEMENTPlacebo

Dextrose (480 mg)

DIETARY_SUPPLEMENTActive

Tary Cherry (480 mg)

Sponsors

Anderson Global Group, LLC
CollaboratorUNKNOWN
Texas A&M University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double (Participant, Investigator)

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* They are healthy males or females ages 30 to 60 years with fasting serum uric acid (UA) levels between 5.5 and 8.0 mg/dl obtained during the familiarization/screening visit; * They have a willingness to provide voluntary, written, informed consent to participate in the study;

Exclusion criteria

* They take prescription (Rx) medications (i.e., Uloric, Krystexxa, etc.) or dietary supplements known to have UA-reducing activity (i.e., black cherry, devil's claw, grape seed extracts, etc.); * They have regular diseases requiring regular prescription (Rx) medications (birth control is allowed); * They have abnormal/out of range values in laboratory tests determined at the familiarization/screening visit; * They have an allergy to tart cherry or immunoglobulin E; * They are pregnant, trying to become pregnant or breastfeeding;

Design outcomes

Primary

MeasureTime frameDescription
Uric Acid ChangesMeasured at baseline (prior to supplementation (Pre)), and after 60, 120, 180 and 240 minutesSerum Uric Acid changes to ingesting a high purine containing meal,

Secondary

MeasureTime frameDescription
Side Effects AssessmentMeasured at baseline prior to supplementation (Pre)Abdominal Side Effects Assessment on a 5 point likert scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026